Haemostatic abnormalities in lung cancer: Prognostic implications

European Journal of Cancer Part A

Volumn 33, Issue 1, 1997, Pages 50-55

  Buccheri, G ^a   Ferrigno, D ^a   Ginardi, C ^b   Zuliani, C ^b  

^a Pulmon Depts of the A Carle Hosp   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

blood coagulation; lung cancer; prethrombotic state; prognosis

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031030245     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00310-3     Document Type: Article

References (29)

1. 1. Trosseau A. Phlegmasia Alba Dolens. Clinique Medicale de L'Hotel-Dieur de Paris, 3rd edition. J-B. Balliere et Fils, Paris, 1865, 654-712.
2. 2. Billroth T. Lectures on Surgical Pathology and Therapeutics (translated from the 8th edition). The New Sydenham Society, London, 1878.
3. 3. Edwards RL, Rickles FR, Moritz TE, et al. Abnormalities of blood coagulation tests in patients with cancer. Am J Clin Pathol 1987, 88, 596-602.
4. 4. Rickles FR, Edwards RL, Barb C, et al. Abnormalities of blood coagulation in patients with cancer: fibrinopeptide. A generation and tumor growth. Cancer 1983, 51, 301-307.
5. 5. Bartoloni C, Guidi L, Tricerri A, et al. Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumors'. Oncology 1992, 49, 426-430.
6. 6. Gabazza EC, Taguchi O, Yamakami T, et al. Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer. Cancer 1992, 70, 2631-2636.
7. 7. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S. Evaluating prethrombotic state in lung cancer using molecular markers. Chest 1993, 103, 196-200.
8. 8. Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S. Correlation between increased granulocyte elastase release and activation of blood activation of blood coagulation in patients with lung cancer. Cancer 1993, 72, 2134-2140.
9. 9. Cavanaugh PC, Sloane BF, Honn KV. Role of the coagulation system in tumor-cell induced platelet aggregation and metastasis. Haemostasis 1988, 18, 37-46.
10. 10. Imaoka S, Sasaki YO, Iwanaga T, Terasawa T. The significance of the fibrin/fibrinogen degradation in serum of carcinoma patients with hematogenous metastasis. Cancer 1985, 58, 1488-1492.
11. 11. Kwaan HC, Keer HN. Fibrinolysis and cancer. Semin Thromb Hemost 1990, 16, 230-235.
12. 12. Zacharski LR, Henderson WG, Rickles FR, et al. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75. Cancer 1984, 53, 2046-2052.
13. 13. Aisner J, Goutsou M, Maurer LH, et al. Intensive combination chemotherapy, concurrent chest irradiation, and warfarin for the treatment of limited-disease small-cell lung cancer: a Cancer and Leukemia Group B pilot study. J Clin Oncol 1992, 10, 1230-1236.
14. 14. Lebeau B, Chastang C, Brechet J-M, et al. Subcutaneous heparin treatment increases survival in small cell lung cancer. Cancer 1994, 74, 38-45.
15. 15. Zubroni CG, Schneiderman MA, Frei E, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960, 11, 7-33.
16. 16. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In Macleod C.M., ed. Evaluation of Chemotherapeutic Agents. Columbia University Press, New York, 1949, 199-205.
17. 17. Ferrigno D, Buccheri G, Camilla T. Prognosis and lung cancer: the contribution of plasma proteins. Oncol Rep 1995, 2, 637-641.
18. 18. Biggi A, Buccheri GF, Ferrigno D, et al. Detection of suspected primary lung cancer by scintigraphy with indium-111-anti-carcinoembryonic antigen monoclonal antibodies (type FO23C5).J Nucl Med 1991, 32, 2064-2068.
19. 19. Buccheri GF, Biggi A, Ferrigno D, et al. Imaging lung cancer by scintigraphy with Indium-111 labeled F(ab′)2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5. Cancer 1992, 70, 749-759.
20. 20. World Health Organization. International Histological Classification of Tumours. Springer-Verlag, Berlin, 1991.
21. 21. UICC. TNM Classification of Malignant Tumours, 4th edition. Springer-Verlag, Berlin, 1987, 69-73.
22. 22. Siegel S. Nonparametric Statistics for the Behavioural Sciences. MacGraw Hill, New York, 1956.
23. 23. Kaplan EL, Meier F. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 58, 457-481.
24. 24. Cox DR. Regression models and life tables. J R Stat Soc 1972, 34, 187-220.
25. 25. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trosseau's syndrome revisited. Blood 1983, 62, 14-31.
26. 26. Owen CAJ, Bowie EJW, Thompson JHJ. The Diagnosis of Bleeding Disorders. 2nd edition. Boston, Little, Brown & Company, 1975.
27. 27. Rapaport SI. Defibrination syndromes. In Williams WJ, Beutler E, Ersvel AJ, Rundles RW, eds. Hematology. New York, McGraw-Hill Book Company, 1977, 1454-1480.
28. 28. Carr JM, McKinney M, McDonagh J. Diagnosis of disseminated intravascular coagulation: role of D-dimer. Am J Clin Pathol 1989, 91, 280-287.
29. 29. Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994, 7, 1350-1364.